Category Archives: Pr Newswire

Smart for Life Reports Significant Balance Sheet Improvement; Achieves Over $9.4 Million in Positive Net Stockholders’ Equity Following Successful Restructuring Efforts

Company Files Annual 10-K Report with Full Financial Results MIAMI, Sept. 23, 2024 (GLOBE NEWSWIRE) — Smart for Life, Inc. (OTC: SMFL) (“Smart for Life” or the “Company”), a distinguished leader in the Health & Wellness sector specializing in the marketing and manufacturing of nutritional supplements and foods, today announced significant progress in strengthening its […]

DBV Technologies Completes Screening for the VITESSE Phase 3 Clinical Trial

Châtillon, France, September 23, 2024 DBV Technologies Completes Screening for the VITESSE Phase 3 Clinical Trial In Q3 2024, DBV exceeded its recruitment goal and successfully closed the screening process for the VITESSE Phase 3 study evaluating the Viaskin® Peanut Patch in peanut allergic children ages 4 – 7 years old Topline results of VITESSE […]

BioVie Inc. Announces Proposed Public Offering

CARSON CITY, Nev., Sept. 23, 2024 (GLOBE NEWSWIRE) — BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for the treatment of advanced liver disease and neurological and neurodegenerative disorders, today announced that it intends to offer to sell shares of its common stock (and/or pre-funded warrants (“Pre-Funded Warrants”) […]

QIAGEN and Bode Technology partner to advance use of GEDmatch PRO forensic genetic genealogy database

QIAGEN chooses Bode Technology as its exclusive global commercial partner to accelerate use of GEDmatch PRO genealogy database in law enforcement and identification of human remains // Collaboration ensures GEDmatch PRO development remains focused on the needs of forensic genealogists and investigators in the U.S. and other countries worldwide // Partnership builds on QIAGEN’s leading […]

Gates Foundation Celebrates Children’s Health and Nutrition Champions at Goalkeepers 2024: Recipe for Progress

Honorees include Brazil’s President Lula and 10 leaders working to improve health and nutrition in their communities NEW YORK, Sept. 24, 2024 /PRNewswire/ — At its event, Goalkeepers 2024: Recipe for Progress, the Bill & Melinda Gates Foundation honored remarkable leaders who are advancing the United Nations Sustainable Development Goals (Global Goals) with solutions to keep people […]

Global Digital Health Leaders Converge in Seoul for HIMSS24 APAC Conference

SEOUL, Korea, Sept. 24, 2024 /PRNewswire/ — The 2024 HIMSS Asia Pacific Health Conference & Exhibition, one of the most influential digital health conferences in the APAC region, will be hosted for the first time in Seoul, Korea. The conference will take place from 1 – 4 October at the Coex Convention & Exhibition Center. The […]

iClick Interactive Asia Group Limited Announces Closing of Disposal of Its Mainland China Enterprise Solutions Business

HONG KONG, Sept. 24, 2024 /PRNewswire/ — iClick Interactive Asia Group Limited (“iClick” or the “Company”) (NASDAQ: ICLK), a renowned marketing cloud platform in China that empowers worldwide brands with full-stack consumer lifecycle solutions, today announced that it has closed its previously announced disposal of its enterprise solutions business in mainland China in accordance with […]

Dubai Cares unveils ‘Rewiring Education: The Climate-Education Nexus’ report

Provides a comprehensive roadmap that bridges education and climate goals and outlines key recommendations to drive meaningful action at the climate-education nexus DUBAI, UAE, Sept. 24, 2024 /PRNewswire/ — Dubai Cares has launched its latest report, “Rewiring Education: The Climate- Education Nexus,” advocating for integrating education and climate action, during the 79th United Nations General […]

Cidara Therapeutics Announces First Subjects Dosed in Phase 2b NAVIGATE Trial Evaluating CD388 for the Prevention of Seasonal Influenza

The Phase 2b trial will enroll 5,000 subjects across clinical sites in the US and UK SAN DIEGO, Sept. 23, 2024 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing […]